PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway
Wei Zhang(Shanghai Jiao Tong University), Baohui Han(Shanghai Jiao Tong University)
Cited by 22
Related Papers
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2017|380
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)
|Lung Cancer|2014|51
Multi‐target angiogenesis inhibitor combined with <scp>PD</scp>‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of <scp>EGFR‐TKI</scp> therapy
|International Journal of Cancer|2023|25
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis
|Cell Death and Disease|2021|22